URGENT CALL TO ACTION: Tell the FDA Not to Approve Pfizer’s mRNA Shots for Infants and Children under Five

Children’s Health Defense (CHD) needs all hands on deck to speak up to the U.S. Food and Drug Administration (FDA). On February 15, a decision will be made that could be devastating to the health of nearly 20 million children in our country.

Don’t Break Our Hearts. Protect Our Health.

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) is scheduled to meet next Tuesday to discuss the Emergency Use Authorization (EUA) of Pfizer’s COVID-19 shots for babies as young as six-months and children up to five years old despite the lack of data to support its use.

U.S. public health officials need to hear from the millions of us who oppose giving unnecessary vaccines to infants and young children who have virtually zero risk of complications or death from COVID. Subjecting healthy children and babies to this vaccine poses a much greater risk through potential severe adverse reactions and even death.

We’re asking all of you to do two things to make sure your voices are heard at this critical moment.

• Email all the members of the VRBPAC committee and the other public officials listed below by going to CHD’s advocacy portal. Make follow up phone calls to each person asking if they’ve received your email. Phone numbers are below.
• Join CHD’s Red Letter Campaign! Mail hand-written notes from you and your child to every public official listed below using red envelopes. Your child’s message can be very simple: “Don’t break our hearts, protect our health.” Also, include your own message explaining why you oppose granting EUA status to these risky vaccines. If you don’t have time to write your own, you can use the one in our advocacy portal. Print this QR CODE and include it in the envelope. It will link to science showing that COVID vaccines are ineffective, unsafe, and unnecessary for our children. Red envelopes are available at many retailers including Staples, Office Depot, Walmart and Amazon. Don’t have time to get red envelopes? Use a regular one and draw red hearts on it.

If an EUA is granted, Pfizer’s pediatric vaccine will be available to nearly 20 million children under the age of five, many of whom already have robust natural immunity. It also will be an important milestone in the pharmaceutical industry’s ultimate goal of getting COVID shots on the recommended childhood schedule, granting them immunity from liability for injuries and deaths from these vaccines in perpetuity.

We absolutely cannot let this happen.

Join CHD in contacting all of these public officials ASAP!

If the form is not working for you, try this page.

Janet Woodcock
Acting FDA Commissioner
FDA, mail stop: HFD-001
10903 New Hampshire Ave., WO51-6133
Silver Spring MD 20993-0002
phone: (301) 796-5400
fax: (301) 847-8752
Janet.Woodcock@fda.hhs.gov
Tweets by DrWoodcockFDA

Rochelle Walensky
Director, Centers for Disease Control and Prevention
Roybal Building 21, Rm 12000
1600 Clifton Rd
Atlanta, GA 30333
phone: (404) 639-7000
Aux7@cdc.gov
Tweets by CDCDirector

Xavier Becerra
Secretary, Health & Human Services
200 Independence Avenue S.W.
Washington, D.C. 20201
c/o Sean McCluskie
xavier.becerra@hhs.gov
Tweets by XavierBecerra

Peter Marks
Director, Center for Biologics Evaluation and Research
FDA, Mail stop: HFM-2
10903 New Hampshire Ave., WO71-7232
Silver Spring MD 20993-0002
phone: (240) 402-8116
fax: (301) 595-1310
Peter.Marks@fda.hhs.gov

Acting Chair, VRBPAC
Arnold Monto, M.D.
Professor of Public Health & Epidemiology
Department of Epidemiology
University of Michigan School of Public Health
Ann Arbor, MI 48109
phone: (734) 764-5453
fax: (734) 764-3192
asmonto@umich.edu

Paula Annunziato, M.D.
Vice President and Therapeutic Area Head
Vaccines Clinical Research
Merck
North Wales, PA 19454
paula.annunziato@merck.com

Captain Amanda Cohn
Chief Medical Officer
National Center for Immunizations and Respiratory Diseases
Centers for Disease Control and Prevention
1600 Clifton Rd
Atlanta, GA 30333 MS C-09
phone: (404) 639-6039
fax: (404) 315-4679
acohn@cdc.gov
anc0@cdc.gov

Hayley Gans, M.D.
Professor of Pediatrics
Department of Pediatrics
Stanford University Medical Center
Stanford, CA 94305
phone: (650) 723-5682
fax: (650) 725-8040
hgans@stanford.edu

Michael Kurilla, M.D., Ph.D.
Director, Division of Clinical Innovation
National Center for Advancing Translation Sciences
National Institutes of Health
Bethesda, MD 20852
phone: (301) 435-0178
Michael.kurilla@nih.gov

H. Cody Meissner, M.D.
Professor of Pediatrics
Tufts University School of Medicine
Director, Pediatric Infectious Disease
Tufts Medical Center
Boston, MA 02111
phone: (617) 636-5227
fax: (617) 636-4300
cmeissner@tuftsmedicalcenter.org

Paul Offit, M.D.
Professor of Pediatrics
Division of Infectious Diseases
Abramson Research Building
The Children’s Hospital of Philadelphia
Philadelphia, PA 19104
phone: (215) 590-2020
offit@chop.edu
Tweets by DrPaulOffit

Steven Pergam, M.D.
Medical Director
Infection Prevention
Seattle Cancer Care Alliance
Seattle, WA 98109
phone: (206) 667-7126
spergam@fredhutch.org
Tweets by PergamIC

Temporary Voting Members (but their votes count all the same)
A. Oveta Fuller, Ph.D.
Associate Professor of Microbiology and Immunology,
University of Michigan Medical School
Ann Arbor, MI 48109
phone: (734) 647-3830
fullerao@umich.edu

James Hildreth, Sr., Ph.D., M.D.
Professor
Department of Internal Medicine
School of Medicine
President and Chief Executive Officer
Meharry Medical College
Nashville, TN 37205
officeofthepresident@mmc.edu
Tweets by JamesEKHildreth

Jeannette Lee, Ph.D.
Professor Department of Biostatistics
University of Arkansas for Medical Sciences
Little Rock, AR 72701
phone: (501) 526-6712
JYLee@uams.edu

Ofer Levy, M.D., Ph.D.
Staff Physician & Principal Investigator
Director, Precision Vaccines Program
Division of Infectious Diseases
Boston Children’s Hospital
Harvard Medical School Associate Member
phone: (617) 919-2900
fax: (617) 730-0254
ofer.levy@childrens.harvard.edu
Tweets by levy_o

Patrick Moore, M.D., M.P.H.
Distinguished and American Cancer Society Professor
Pittsburgh Foundation Chair in Innovative Cancer Research
University of Pittsburgh Cancer Institute
Pittsburgh, PA 15213
phone: (412) 623-7721
psm9@pitt.edu

Michael Nelson, M.D., Ph.D.
Professor of Medicine
Asthma, Allergy and Immunology Division
UVA Division of Asthma, Allergy & Immunology
PO Box 801355
Charlottesville, VA 22908
phone: (434) 297-8399
fax: (434) 924-5779
mrn8d@virginia.edu

Stanley Perlman, M.D., Ph.D.
Professor of Pediatrics
University of Iowa
3-712 Bowen Science Building (BSB)
51 Newton Rd
Iowa City, IA 52242
phone: (319) 335-8549
stanley-perlman@uiowa.edu

Jay Portnoy, M.D.
Director,
Division of Allergy, Asthma & Immunology
Children’s Mercy Hospitals & Clinics
2401 Gillham Road Kansas City, MO 64108
phone: (816) 960-8885
fax: (816) 960-8888
Jportnoy@cmh.edu

Eric Rubin, M.D., Ph.D.
Editor-in-Chief
New England Journal of Medicine
Adjunct Professor
Harvard TH Chan School of Public Health
665 Huntington Ave
Building 1, Room 811
Boston, MA 02115
phone: (617) 432-3335
erubin@hsph.harvard.edu
erubin@nejm.org

Mark Sawyer, M.D.
Professor of Clinical Pediatrics
8110 Birmingham Way
Bldg. 28, 1st Floor
San Diego, CA 92123
phone: (858) 966-7785
fax: (858) 966-8658
mhsawyer@ucsd.edu

Melinda Wharton, M.D., MPH
Associate Director for Vaccine Policy
National Center for Immunization and Respiratory Diseases,
Centers for Disease Control and Prevention,
1600 Clifton Road, Mailstop E05,
Atlanta, GA 30333
phone: (404) 639.8755
fax: (404) 639.8626
mew2@cdc.gov

Hana El Sahly, M.D.
Chair
Expertise: Vaccines, Infectious Diseases
Associate Professor
Baylor College of Medicine
7200 Cambridge Street 8th Floor Suite B
Houston, TX 77030
713.798.2058
hanae@bcm.edu

Adam C. Berger, Ph.D.
Director, Division of Clinical and Healthcare Research Policy
National Institutes of Health
6705 Rockledge Drive, Suite 630
Bethesda, MD 20892
301-827-9676
adam.berger@nih.gov

Henry H. Bernstein, D.O., MHCM, FAAP
Professor of Pediatrics
Cohen Children’s Medical Center
410 Lakeville Road, Suite 311
New Hyde Park, NY 11042
Telephone: 516-838-6415 (office)
FAX: 516-465-5399
hbernstein@northwell.edu

Archana Chatterjee, M.D., Ph.D.
Vice President for Medical Affairs
Rosalind Franklin University of Medicine and Science
3333 Green Bay Road
North Chicago, IL 60064
Phone: 847-578-3301
FAX: 847-578-3345
Archana.Chatterjee@RosalindFranklin.edu

Holly Janes, Ph.D.
Associate Member
Fred Hutchinson Cancer Research Center
1100 Fairview Avenue North, M2-C200
P.O. Box 19024
Seattle, WA 98109
206.667.6353 (office)
hjanes@fredhutch.org

David Kim, M.D., M.S., M.H.A.
CAPT, U.S. Public Health Services
U.S. Department of Health and Human Services
330 C Street SW, Suite L600
Washington, DC 20024
(202) 795-7636
david.kim@hhs.gov

Andrea Shane, M.D., M.P.H., M.Sc.
Professor of Pediatrics
Emory University School of Medicine
2015 Uppergate Drive NE, Rm. 504A
Atlanta, GA 30322
Telephone: 404-727-9880 (direct)
Fax: 404-727-8249
ashane@emory.edu

Geeta K. Swamy, M.D.
Senior Associate Dean
Duke University
Box 3967 Med Ctr
Durham, NC 27710
(919) 681-5220
swamy002@mc.duke.edu

Gregg Sylvester, M.D., M.P.H.
Vice President
Medical Affairs
Seqirus Inc.
Summit, NJ 07901
470 Burnt Mill Road
Wilmington, DE 19807
302-272-0653
gcsylvester@gmail.com

The post URGENT CALL TO ACTION: Tell the FDA Not to Approve Pfizer’s mRNA Shots for Infants and Children under Five appeared first on Children's Health Defense.

© 09 Feb 2022 Children’s Health Defense, Inc. This work is reproduced and distributed with the permission of Children’s Health Defense, Inc. Want to learn more from Children’s Health Defense? Sign up for free news and updates from Robert F. Kennedy, Jr. and the Children’s Health Defense. Your donation will help to support us in our efforts.